Advaxis, Inc. (NASDAQ:ADXS) Expected to Post Earnings of -$1.24 Per Share

Share on StockTwits

Wall Street analysts expect Advaxis, Inc. (NASDAQ:ADXS) to post earnings of ($1.24) per share for the current quarter, according to Zacks. Zero analysts have made estimates for Advaxis’ earnings. Advaxis posted earnings per share of ($4.05) in the same quarter last year, which suggests a positive year-over-year growth rate of 69.4%. The firm is scheduled to report its next quarterly earnings results on Monday, September 9th.

According to Zacks, analysts expect that Advaxis will report full year earnings of ($2.70) per share for the current year. For the next financial year, analysts expect that the firm will report earnings of ($2.41) per share. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that cover Advaxis.

A number of equities research analysts have recently issued reports on ADXS shares. ValuEngine lowered shares of Zumiez from a “hold” rating to a “sell” rating in a report on Tuesday, July 2nd. HC Wainwright reaffirmed a “neutral” rating on shares of Aerpio Pharmaceuticals in a report on Wednesday, June 12th. Finally, Zacks Investment Research raised shares of Flagstar Bancorp from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a report on Monday, July 8th.

NASDAQ ADXS traded down $0.16 on Thursday, hitting $1.41. The company had a trading volume of 6,794 shares, compared to its average volume of 215,278. Advaxis has a 12-month low of $1.50 and a 12-month high of $24.60. The stock has a market capitalization of $12.55 million, a P/E ratio of -0.07 and a beta of 3.30. The company’s fifty day moving average price is $2.27.

Institutional investors have recently added to or reduced their stakes in the company. Deutsche Bank AG raised its holdings in shares of Advaxis by 5,970.3% in the fourth quarter. Deutsche Bank AG now owns 562,294 shares of the biotechnology company’s stock worth $106,000 after buying an additional 553,031 shares during the last quarter. Two Sigma Investments LP raised its holdings in shares of Advaxis by 2,468.2% in the fourth quarter. Two Sigma Investments LP now owns 369,815 shares of the biotechnology company’s stock worth $70,000 after buying an additional 355,415 shares during the last quarter. Finally, BlackRock Inc. raised its holdings in shares of Advaxis by 3.1% in the fourth quarter. BlackRock Inc. now owns 1,446,288 shares of the biotechnology company’s stock worth $275,000 after buying an additional 43,368 shares during the last quarter. 24.40% of the stock is owned by institutional investors and hedge funds.

About Advaxis

Advaxis, Inc, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of Listeria monocytogenes (Lm) technology based antigen delivery product in the United States. It is developing therapies for HPV-related cancers using axalimogene filolisbac (AXAL) for the treatment of head and neck cancer.

Further Reading: The primary rules of Elliott Wave theory

Get a free copy of the Zacks research report on Advaxis (ADXS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Advaxis (NASDAQ:ADXS)

Receive News & Ratings for Advaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advaxis and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Swiss National Bank Lowers Position in Molson Coors Brewing Co
Swiss National Bank Lowers Position in Molson Coors Brewing Co
Swiss National Bank Buys 158,700 Shares of PerkinElmer, Inc.
Swiss National Bank Buys 158,700 Shares of PerkinElmer, Inc.
Swiss National Bank Sells 2,900 Shares of New Oriental Education & Tech Grp
Swiss National Bank Sells 2,900 Shares of New Oriental Education & Tech Grp
Swiss National Bank Acquires 92,200 Shares of Shaw Communications Inc
Swiss National Bank Acquires 92,200 Shares of Shaw Communications Inc
Swiss National Bank Sells 24,700 Shares of Noble Energy, Inc.
Swiss National Bank Sells 24,700 Shares of Noble Energy, Inc.
Occidental Asset Management LLC Buys 3,622 Shares of JPMorgan Chase & Co.
Occidental Asset Management LLC Buys 3,622 Shares of JPMorgan Chase & Co.


© 2006-2019 Ticker Report